论文部分内容阅读
目的:恩替卡韦与益肝活血化纤中药汤剂对于乙肝纤维化病患产生的影响分析。方法:在2016年1月份到2017年10月份收治的乙肝纤维化病患中随机选取80例进行中西医用药研究,将其中40例乙肝纤维化病患分入西药组,行恩替卡韦单一用药治疗,而另40例乙肝纤维化病患纳入中西医联合组,在西药组用药基础上增加益肝活血化纤中药汤剂治疗,比较这两组病患的肝功能情况、肝纤维化情况以及副作用情况。结果:用药后,中西医联合组病患的肝功能情况、肝纤维化情况改善要比西药组要好,两组数值有统计学研究比较差异,而在副作用方面,两组病患差异不大,两组数值没有统计学研究比较意义。结论:恩替卡韦与益肝活血化纤中药汤剂治疗可改善乙肝纤维化病患的肝功能和肝纤维化,副作用较低,值得推广。
Objective: To analyze the influence of Entecavir and Yigan Huoxue Chemical Fiber decoction on patients with Hepatic fibrosis. Methods: Eighty randomly selected 80 patients with hepatitis B from January 2016 to October 2017 were enrolled in the study of traditional Chinese and western medicine. 40 cases of hepatitis B patients were divided into western medicine group and single entecavir treatment, The other 40 patients with hepatitis B were included in the combination of Chinese and Western medicine on the basis of Western medicine group to increase the liver and blood circulation of traditional Chinese medicine decoction treatment, liver function, liver fibrosis and side effects in these two groups were compared. Results: After treatment, the liver function and hepatic fibrosis in Integrative Medicine group were better than that in Western medicine group. There were statistically significant differences between the two groups, but there were no significant differences in side effects between the two groups. No statistical significance of the two groups of statistics. Conclusion: Entecavir and Yiganhuoxue Decoction decoction can improve liver function and liver fibrosis in patients with hepatitis B fibrosis, with low side effects and worthy of promotion.